In a regulatory filing, the company states: "Recursion Pharmaceuticals confirms that it does not hold any deposits or securities or maintain any accounts at Silicon Valley Bank. We are currently evaluating counterparty risk and have discovered no material risk at this time."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RXRX: